Urogenit Tract Infect.  2017 Aug;12(2):89-94. 10.14777/uti.2017.12.2.89.

Type Distribution of Human Papillomavirus in Genital Warts of Korean Men

• Ryu KH
• Cho JH
• Lee MC
• Jung TY

• KMID: 2389575
• DOI: http://doi.org/10.14777/uti.2017.12.2.89

Abstract

PURPOSE
To analyze the distribution of human papillomavirus (HPV) types and the characteristics of genital condyloma in Korean men.
MATERIALS AND METHODS
Between January 2015 and December 2015, we reviewed the medical charts of 435 male patients diagnosed with genital condyloma. A total of 441 samples were identified. The detection rate of each HPV type and its associated characteristics (age, number of HPV types, low-risk and/or high-risk types, number of lesions) were analyzed. Our sample population was divided into two groups: The non-urethral condyloma group and the urethral condyloma group. In addition, subgroup analysis was also performed.
RESULTS
Among the total 441 specimens, 409 (92.7%) were non-urethral condyloma and 32 (7.3%) were urethral condyloma. Single-type infection was observed in 56.7% and multiple-type infection was seen in 43.3%. HPV type 6 and type 11 were the most common types in total genital condyloma and subgroups. HPV type 11, which was detected in 43.8% of those in the urethral condyloma group and in 22.0% of those in the non-urethral condyloma group (p=0.009), showed a statistically significant difference with respect to the type-specific detection rate.
CONCLUSIONS
As in previous studies, our study also showed that HPV type 6 was the most prevalent type among all genital condylomas, followed by HPV type 11. A subgroup analysis also showed the same result.

Keyword

Human papilloma virus; Genital wart; Condyloma acuminata

MeSH Terms

Condylomata Acuminata*
Humans*
Male
Papillomaviridae

Reference

1.Giuliano AR., Anic G., Nyitray AG. Epidemiology and pathology of HPV disease in males. Gynecol Oncol. 2010. 117(2 Suppl):S15–9.

2.de Villiers EM., Fauquet C., Broker TR., Bernard HU., zur Hausen H. Classification of papillomaviruses. Virology. 2004. 324:17–27.

3.Juckett G., Hartman-Adams H. Human papillomavirus: clinical manifestations and prevention. Am Fam Physician. 2010. 82:1209–13.

4.zur Hausen H. Papillomaviruses in the causation of human cancers-a brief historical account. Virology. 2009. 384:260–5.

5.Jimenez-Pacheco A., Exposito-Ruiz M., Arrabal-Polo MA., Lopez-Luque AJ. Meta-analysis of studies analyzing the role of human papillomavirus in the development of bladder carcinoma. Korean J Urol. 2012. 53:240–7.

6.Canepa P., Orsi A., Martini M., Icardi G. HPV related diseases in males: a heavy vaccine-preventable burden. J Prev Med Hyg. 2013. 54:61–70.

7.Oriel JD. Natural history of genital warts. Br J Vener Dis. 1971. 47:1–13.

8.Garland SM., Steben M., Sings HL., James M., Lu S., Railkar R, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis. 2009. 199:805–14.

9.Arroyo LS., Basaras M., Arrese E., Hernaez S., Esteban V., Cisterna R. Distribution of genital human papillomavirus genotypes in benign clinical manifestations among men from Northern Spain. BMC Public Health. 2016. 16:81.

10.Aynaud O., Piron D., Bijaoui G., Casanova JM. Developmental factors of urethral human papillomavirus lesions: correlation with circumcision. BJU Int. 1999. 84:57–60.

11.Aguilar LV., Lazcano-Ponce E., Vaccarella S., Cruz A., Hernandez P., Smith JS, et al. Human papillomavirus in men: comparison of different genital sites. Sex Transm Infect. 2006. 82:31–3.

12.Watson RA. Human papillomavirus: confronting the epidemica urologist's perspective. Rev Urol. 2005. 7:135–44.

13.Pudney J., Anderson D. Innate and acquired immunity in the human penile urethra. J Reprod Immunol. 2011. 88:219–27.

14.Egawa N., Egawa K., Griffin H., Doorbar J. Human papillo-maviruses; epithelial tropisms, and the development of neoplasia. Viruses. 2015. 7:3863–90.

15.Anic GM., Lee JH., Stockwell H., Rollison DE., Wu Y., Papenfuss MR, et al. Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study. J Infect Dis. 2011. 204:1886–92.

16.Park SJ., Seo J., Ha SH., Jung GW. Prevalence and determinants of high-risk human papillomavirus infection in male genital warts. Korean J Urol. 2014. 55:207–12.

17.Freire MP., Pires D., Forjaz R., Sato S., Cotrim I., Stiepcich M, et al. Genital prevalence of HPV types and co-infection in men. Int Braz J Urol. 2014. 40:67–71.

18.Salehi-Vaziri M., Sadeghi F., Bokharaei-Salim F., Younesi S., Alinaghi S., Monavari SH, et al. The prevalence and genotype distribution of human papillomavirus in the genital tract of males in Iran. Jundishapur J Microbiol. 2015. 8:e21912.

19.Kwon T., Moon KH., Yang SH., Roh MC., Lee SH., Kim JW, et al. Multiple human papillomavirus infection is associated with high-risk infection in male genital warts in Ulsan, Korea. J Korean Med Sci. 2016. 31:371–5.

20.Dunne EF., Nielson CM., Stone KM., Markowitz LE., Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis. 2006. 194:1044–57.

21.Albero G., Castellsague X., Lin HY., Fulp W., Villa LL., Lazcano-Ponce E, et al. Male circumcision and the incidence and clearance of genital human papillomavirus (HPV) infection in men: the HPV Infection in men (HIM) cohort study. BMC Infect Dis. 2014. 14:75.

22.Taylor S., Bunge E., Bakker M., Castellsague X. The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature. BMC Infect Dis. 2016. 16:293.

23.Kjaer SK., Munk C., Winther JF., Jorgensen HO., Meijer CJ., van den Brule AJ. Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev. 2005. 14:1528–33.